RSS

Provepharm

Pharma development company, Provepharm’s ProvayBlue (methylene blue) Injection has been given New Drug Application status from the US Food and Drug Administration (FDA) under its accelerated approval regulations more

News

Out of the blue: Provepharm and Dr Franz Kohler Chemie (DFKC), have entered into a partnership to launch Provepharm’s drug product Methylthioninium chloride Proveblue more

News